OnKure Therapeutics (OKUR) Return on Equity [ROE] (2021 - 2026)
OnKure Therapeutics (OKUR) reported Return on Equity [ROE] of -34.87% for Q2 2026, up 40.73 percentage points from -75.60% a year earlier and up 16.33 percentage points from the prior quarter.
Powered by 
Analysis
OnKure Therapeutics (OKUR) Return on Equity [ROE] (2021 - 2026) Analysis & Trends
For FY2025, OnKure Therapeutics posted Return on Equity [ROE] of -78.69%, up 5428.46 percentage points from FY2024.
- Return on Equity [ROE] has a four-year change of -2.92 percentage points (FY2021 to FY2025).
- By year, Return on Equity [ROE] came in at -5507.15% in FY2024, -116.06% in FY2022 (-40.29 pp) and -75.77% in FY2021.
- The Q2 2026 figure ranks as the highest quarterly Return on Equity [ROE] since Q1 2022.
- The high point for year-over-year Return on Equity [ROE] in five years was Q2 2026 (a gain of 40.73 percentage points); the low point was Q4 2023 (a drop of 376.95 percentage points).
- Per Business Quant data, the three quarters before Q2 2026 came in at -51.20% (Q1 2026), -102.69% (Q4 2025) and -93.48% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROE (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,169.70 Bn | 1,138.29 Bn | 19.71 Bn | 82.09% |
| 2 | Johnson & Johnson | 647.50 Bn | 567.36 Bn | 17.30 Bn | 19.33% |
| 3 | AbbVie | 504.26 Bn | 477.37 Bn | 12.70 Bn | - |
| 4 | Merck | 368.38 Bn | 322.75 Bn | 12.21 Bn | 7.21% |
| 5 | Novartis Ag | 303.14 Bn | 267.13 Bn | 11.24 Bn | 31.52% |
| 6 | Astrazeneca | 268.24 Bn | 241.93 Bn | 12.86 Bn | 21.39% |
| 7 | Amgen | 242.50 Bn | 197.90 Bn | 7.24 Bn | 83.75% |
| 8 | Gilead Sciences | 194.79 Bn | 168.99 Bn | 6.22 Bn | -18.38% |
| 9 | Pfizer | 173.14 Bn | 119.78 Bn | 10.94 Bn | 4.97% |
| 10 | OnKure Therapeutics | 125.42 Mn | -372.50 Mn | - | -34.87% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -34.87% |
| Mar 31, 2026 | -51.20% |
| Dec 31, 2025 | -102.69% |
| Sep 30, 2025 | -93.48% |
| Jun 30, 2025 | -75.60% |
| Mar 31, 2025 | -63.61% |
| Dec 31, 2023 | -563.84% |
| Sep 30, 2023 | -58.68% |
| Jun 30, 2023 | -59.71% |
| Mar 31, 2023 | -348.72% |
| Dec 31, 2022 | -186.88% |
| Sep 30, 2022 | -42.26% |
| Jun 30, 2022 | -37.63% |
| Mar 31, 2022 | -32.29% |
| Dec 31, 2021 | -26.25% |
| Sep 30, 2021 | -21.90% |
| Jun 30, 2021 | -46.77% |
API Access
OnKure Therapeutics Return on Equity [ROE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=OKUR&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-equity-[roe]", "ticker": "OKUR", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=OKUR&period=max&api_key=YOUR_API_KEY");
const data = await res.json();